Adel Elmoselhi

7PUBLICATIONS
13CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Preventative health careRespiratory diseasesMedical infection agents (incl. prions)Microbial genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 28, 2026
Correction: Bajbouj et al. Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer. Int. J. Mol. Sci. 2022, 23, 4408.

Khuloud Bajbouj, Rizwan Qaisar, Mohammed A Alshura

|Apr 03, 2025
High prevalence of elevated blood pressure (prehypertension) and hypertension among undergraduate university students in the UAE: a serious health concern.

Yasser Amer Abd Alsamad, Bessan Musa Saleh Jaffal, Khaleel Rajaee Ibrahim Shuhait

|Mar 29, 2023
Advantages of Understanding the Molecular Mechanisms of Angiogenesis in Various Physiological and Pathological Conditions.

Adel B Elmoselhi

|Mar 23, 2023
Circulating microRNAs as potential biomarkers of early vascular damage in vitamin D deficiency, obese, and diabetic patients.

Adel B Elmoselhi, Mohamed Seif Allah, Amal Bouzid

|Nov 26, 2022
Effect of Microgravity on the Gut Microbiota Bacterial Composition in a Hindlimb Unloading Model.

Ruqaiyyah Siddiqui, Rizwan Qaisar, Naveed Ahmed Khan

|Apr 23, 2022
Synergistic Anti-Angiogenic Effect of Combined VEGFR Kinase Inhibitors, Lenvatinib, and Regorafenib: A Therapeutic Potential for Breast Cancer.

Khuloud Bajbouj, Rizwan Qaisar, Mohammed A Alshura

Pageof 2

Frequent Collaborators

2 joint publications

Khuloud Bajbouj

2 joint publications

Zeinab Ibrahim

2 joint publications

Mohamad B Alebaji

2 joint publications

Maha M Saber-Ayad